Eligible commercially insured patients who are prescribed HEMLIBRA for an FDA-approved use can receive up to $15,000 per calendar year for drug costs. For more information, see full program Terms and Conditions.
Eligible commercially insured patients who are prescribed HEMLIBRA for an FDA-approved use can receive up to $15,000 per calendar year for drug costs. For more information, see full program Terms and Conditions.
At any time, click this to change word size.